Search Results

There are 5610 results for: content related to: Vinpocetine and α-tocopherol prevent the increase in DA and oxidative stress induced by 3- NPA in striatum isolated nerve endings

  1. Eburnamine derivatives and the brain

    Medicinal Research Reviews

    Volume 25, Issue 6, November 2005, Pages: 737–757, Ádám Vas and Balázs Gulyás

    Version of Record online : 12 SEP 2005, DOI: 10.1002/med.20043

  2. You have free access to this content
    Identification and quantification of vinpocetine and picamilon in dietary supplements sold in the United States

    Drug Testing and Analysis

    Volume 8, Issue 3-4, March-April 2016, Pages: 334–343, Bharathi Avula, Amar G. Chittiboyina, Satyanarayanaraju Sagi, Yan-Hong Wang, Mei Wang, Ikhlas A. Khan and Pieter A. Cohen

    Version of Record online : 1 OCT 2015, DOI: 10.1002/dta.1853

  3. General neuropharmacology of vinpocetine: A putative cerebral activator

    Drug Development Research

    Volume 11, Issue 2, 1987, Pages: 107–115, Dr Kevin L. Keim and Pauliana C. Hall

    Version of Record online : 5 OCT 2004, DOI: 10.1002/ddr.430110205

  4. Vinpocetine for acute ischaemic stroke

    Intervention Review

    The Cochrane Library

    Dániel Bereczki and István Fekete

    Published Online : 23 JAN 2008, DOI: 10.1002/14651858.CD000480.pub2

  5. On the possible role of central monoaminergic systems in the central nervous system actions of vinpocetine

    Drug Development Research

    Volume 14, Issue 3-4, 1988, Pages: 263–279, Béla Kiss and László Szporny

    Version of Record online : 5 OCT 2004, DOI: 10.1002/ddr.430140318

  6. Vinpocetine for cognitive impairment and dementia

    Intervention Review

    The Cochrane Library

    Szabolcs Szatmári and Peter Whitehouse

    Published Online : 20 JAN 2003, DOI: 10.1002/14651858.CD003119

  7. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects

    Acta Neurologica Scandinavica

    Volume 106, Issue 6, December 2002, Pages: 325–332, B. Gulyás, C. Halldin, J. Sandell, P. Karlsson, J. Sóvágó, E. Kárpáti, B. Kiss, Á. Vas, Z. Cselényi and L. Farde

    Version of Record online : 11 DEC 2002, DOI: 10.1034/j.1600-0404.2002.01302.x

  8. The Safety and Lack of Efficacy of Vinpocetine in Alzheimer's Disease

    Journal of the American Geriatrics Society

    Volume 37, Issue 6, June 1989, Pages: 515–520, Leon J. Thal, David P. Salmon, Bruce Lasker, D. Bower and Melville R. Klauber

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1989.tb05682.x

  9. You have free access to this content
    Neuroprotective Effects of Vinpocetine and its Major Metabolite Cis-apovincaminic Acid on NMDA-Induced Neurotoxicity in a Rat Entorhinal Cortex Lesion Model

    CNS Neuroscience & Therapeutics

    Volume 15, Issue 2, June 2009, Pages: 89–99, Csaba Nyakas, Klára Felszeghy, Róbert Szabó, Jan N. Keijser, Paul G.M. Luiten, Zsolt Szombathelyi and Károly Tihanyi

    Version of Record online : 6 MAY 2009, DOI: 10.1111/j.1755-5949.2009.00078.x

  10. [3H]Noradrenaline-releasing action of vinpocetine in the isolated main pulmonary artery of the rabbit

    Journal of Pharmacy and Pharmacology

    Volume 38, Issue 9, September 1986, Pages: 668–673, TÜNde Pauló, Péter T. Tóth, Tinh Thi Nguyen, Lilla Forgács, TamáS L. TÖRÖK and Kálmán Magyar

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1986.tb03107.x

  11. A Double-Blind Placebo Controlled Evaluation of the Safety and Efficacy of Vinpocetine in the Treatment of Patients with Chronic Vascular Senile Cerebral Dysfunction

    Journal of the American Geriatrics Society

    Volume 35, Issue 5, May 1987, Pages: 425–430, Roberto Balestreri, Luigi Fontana and Federico Astengo

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1987.tb04664.x

  12. Multidisciplinary approach on characterizing a mechanochemically activated composite of vinpocetine and crospovidone

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 3, March 2011, Pages: 915–932, Dritan Hasa, Dario Voinovich, Beatrice Perissutti, Alois Bonifacio, Mario Grassi, Erica Franceschinis, Stefano Dall'Acqua, Manuela Speh, Janez Plavec and Sergio Invernizzi

    Version of Record online : 13 SEP 2010, DOI: 10.1002/jps.22331

  13. Acute and Chronic Effects of Vinpocetine on Cerebral Hemodynamics and Neuropsychological Performance in Multi-infarct Patients

    The Journal of Clinical Pharmacology

    Volume 45, Issue 9, September 2005, Pages: 1048–1054, Dr Vendel Kemény, Dr Sándor Molnár, Dr Mónika Andrejkovics, Dr Attila Makai and Dr László Csiba

    Version of Record online : 19 MAR 2013, DOI: 10.1177/0091270005279363

  14. You have free access to this content
    Implication of Calmodulin-Dependent Phosphodiesterase Type 1 During Bovine Sperm Capacitation

    Journal of Andrology

    Volume 24, Issue 1, January-February 2003, Pages: 104–112, Valérie Fournier, Pierre Leclerc, Nathaly Cormier and Janice L. Bailey

    Version of Record online : 2 JAN 2013, DOI: 10.1002/j.1939-4640.2003.tb02648.x

  15. Effect of vinpocetine on age-related differences in brain function of aged fischer rats

    Drug Development Research

    Volume 14, Issue 3-4, 1988, Pages: 325–333, Ronald R. Notvest, Tracey A. Emrey and John J. Inserra

    Version of Record online : 5 OCT 2004, DOI: 10.1002/ddr.430140325

  16. Vinpocetine facilitates noradrenaline release in rat brain cortex slices

    Drug Development Research

    Volume 14, Issue 3-4, 1988, Pages: 285–291, Dr. E. Schlicker, R. Betz and M. Göthert

    Version of Record online : 5 OCT 2004, DOI: 10.1002/ddr.430140320

  17. Brain Uptake and Plasma Metabolism of [11C]Vinpocetine: A Preliminary PET Study in a Cynomolgus Monkey

    Journal of Neuroimaging

    Volume 9, Issue 4, October 1999, Pages: 217–222, Balázs Gulyás, Christer Halldin, Per Karlsson, Yuan-H. Chou, Cari-Gunnar Swahn, Peter Bönöck, Margit Paróczai and Lars Farde

    Version of Record online : 4 FEB 2016, DOI: 10.1111/jon199994217

  18. You have free access to this content
    The anti-seizure drugs vinpocetine and carbamazepine, but not valproic acid, reduce inflammatory IL-1β and TNF-α expression in rat hippocampus

    Journal of Neurochemistry

    Volume 130, Issue 6, September 2014, Pages: 770–779, Carlos D. Gómez, Rudolf M. Buijs and María Sitges

    Version of Record online : 27 JUN 2014, DOI: 10.1111/jnc.12784

  19. Cerebral Effects of a Single Dose of Intravenous Vinpocetine in Chronic Stroke Patients: A PET Study

    Journal of Neuroimaging

    Volume 8, Issue 4, October 1998, Pages: 197–204, Szabolcs Szakall, Istvan Boros, Laszlo Balkay, Miklos Emri, Istvan Fekete, Levente Kerenyi, Szabolcs Lehel, Terez Marian, Tamas Molnar, Jozsef Varga, Laszlo Galuska, Lajos Tron, Daniel Bereczki, Laszlo Csiba and Balazs Gulyas

    Version of Record online : 4 FEB 2016, DOI: 10.1111/jon199884197

  20. Calcium antagonist activity of vinpocetine and vincamine in several models of cerebral ischaemia

    Drug Development Research

    Volume 14, Issue 3-4, 1988, Pages: 297–304, Jean-Claude Lamar, Hervé Poignet, Michèle Beaughard and Georges Dureng

    Version of Record online : 5 OCT 2004, DOI: 10.1002/ddr.430140322